V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003686 | 210011783 | 1.5 | 54.1 | Adjuvant (A) | 2019-09-11 | 2020-01-02 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 101457830 |
| 210003689 | 210011784 | null | 121.8 | null | 2019-08-27 | 2019-08-28 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101857012 |
| 210003690 | 210011785 | 0 | 75.2 | Palliative (P) | 2021-02-21 | 2021-04-11 | Eribulin | 02 | N | ERIBULIN | 100856400 |
| 210003691 | 210011786 | 1.6 | 55.3 | Neo-adjuvant (N) | null | 2019-03-08 | Capecitabine | null | N | CAPECITABINE | 100478792 |
| 210003698 | 210011789 | 1.7 | 107 | Palliative (P) | null | 2021-03-03 | Capecitabine | 02 | N | CAPECITABINE | 100105527 |
| 210003706 | 210011792 | null | null | Palliative (P) | null | 2020-03-08 | Carboplatin 21day + Paclitaxel 7day | 02 | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100598518 |
| 210003707 | 210011793 | 1.7 | 81 | Palliative (P) | 2017-04-05 | 2017-04-05 | null | 02 | N | NAB-PACLITAXEL | 101126331 |
| 210003714 | 210011795 | null | null | null | 2022-02-27 | 2022-04-05 | Capecitabine | 02 | null | CAPECITABINE | 101340915 |
| 210003715 | 210011796 | 1.54 | 77.7 | Palliative (P) | 2014-12-04 | 2018-03-07 | Carboplatin AUC 6 - 10 | 02 | N | NAB-PACLITAXEL | 100242146 |
| 210003716 | 210011797 | null | null | null | null | 2020-10-08 | Letrozole + Palbociclib | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100856886 |
| 210003717 | 210011798 | 1.67 | 82 | Palliative (P) | 2018-07-31 | 2018-08-02 | Cyclophosphamide + Docetaxel | 02 | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100417507 |
| 210003719 | 210011799 | 1.78 | 95.8 | null | 2019-05-25 | 2019-06-07 | null | N | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 101426308 |
| 210003721 | 210011801 | 1.64 | 65 | Palliative (P) | 2020-03-12 | 2020-04-03 | Eribulin | null | N | ERIBULIN | 100577965 |
| 210003722 | 210011802 | 1.6 | 80.9 | Palliative (P) | 2017-04-16 | 2017-07-09 | null | N | N | FULVESTRANT + PALBOCICLIB | 100420307 |
| 210003723 | 210011803 | 1.58 | 76.7 | null | 2019-11-21 | 2019-12-02 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100832036 |
| 210003725 | 210011804 | 1.7 | 70.7 | Palliative (P) | 2017-10-18 | 2017-11-05 | EC | 02 | N | EC | 100388097 |
| 210003727 | 210011805 | 1.62 | 93.3 | null | null | 2016-10-09 | CARBO + DOCETAXEL + TRASTUZUMAB | N | null | FULVESTRANT + PALBOCICLIB | 101141121 |
| 210003729 | 210011807 | 1.71 | 75.4 | Neo-adjuvant (N) | 2019-11-21 | 2020-04-15 | GemCarbo Days 1+8 | 02 | N | EC | 100347717 |
| 210003735 | 210011808 | 1.67 | 94.5 | Adjuvant (A) | 2019-06-21 | 2019-06-26 | Paclitaxel+Trastuzumab wkly Maint | null | null | PACLITAXEL + TRASTUZUMAB | 100843950 |
| 210003736 | 210011809 | 1.7 | 79.4 | Palliative (P) | 2018-05-04 | 2019-08-13 | TRASTUZUMAB EMTANSINE | N | N | NAB-PACLITAXEL | 101855705 |
| 210003745 | 210011814 | 0 | 72.5 | Palliative (P) | 2018-04-03 | 2018-04-10 | null | 01 | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101476880 |
| 210003747 | 210011815 | 1.6 | 72.7 | Palliative (P) | 2021-05-25 | 2021-06-03 | ATEZOLIZUMAB + NAB PACLITAXEL | 02 | N | PACLITAXEL + TRASTUZUMAB | 101834068 |
| 210003748 | 210011816 | 1.73 | 75.8 | Palliative (P) | 2017-01-20 | 2017-02-24 | TCH (21 day Trastuzumab) Maint | null | N | PACLITAXEL + TRASTUZUMAB | 101091256 |
| 210003749 | 210011817 | 1.71 | 57.4 | Neo-adjuvant (N) | 2020-08-06 | 2020-08-12 | null | 02 | N | PACLITAXEL + TRASTUZUMAB | 101397605 |
| 210003750 | 210011818 | null | 48.85 | null | 2021-12-30 | 2022-01-23 | Capecitabine | 01 | null | CAPECITABINE | 101617762 |
| 210003755 | 210011822 | 1.66 | 86.7 | Adjuvant (A) | 2016-04-01 | 2016-04-01 | Capecitabine | 02 | N | CAPECITABINE | 100206801 |
| 210003764 | 210011826 | 1.54 | 61.3 | Adjuvant (A) | null | 2019-10-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + TRASTUZUMAB | 101029123 |
| 210003767 | 210011827 | 1.5 | 61.2 | Adjuvant (A) | null | 2020-05-06 | Capecitabine | null | N | CAPECITABINE | 100759298 |
| 210003768 | 210011828 | 1.54 | 77.4 | Adjuvant (A) | 2020-01-24 | 2021-02-07 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | ABEMACICLIB + FULVESTRANT | 101547987 |
| 210003770 | 210011829 | 1.62 | 0 | null | 2019-01-02 | 2019-01-18 | Carboplatin + Docetaxel | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101804234 |
| 210003773 | 210011830 | 0 | 72.1 | Adjuvant (A) | null | 2022-03-29 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101108908 |
| 210003777 | 210011833 | 1.64 | 86 | null | 2021-12-09 | 2021-12-23 | Capecitabine | 01 | null | CAPECITABINE | 101028848 |
| 210003778 | 210011834 | 1.58 | 58.9 | null | 2019-04-09 | 2019-04-22 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | AC | 100265116 |
| 210003782 | 210011837 | 1.7 | 66.7 | null | null | 2017-08-23 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100450489 |
| 210003790 | 210011839 | 1.73 | 68.7 | null | 2018-11-20 | 2018-11-26 | FEC 60 or 75 | 02 | null | FEC | 101234165 |
| 210003796 | 210011842 | 1.68 | 88.4 | null | 2020-05-21 | 2020-06-06 | Gemcitabine weekly | 02 | null | VINORELBINE | 100395150 |
| 210003798 | 210011844 | 1.68 | 70.9 | Adjuvant (A) | 2020-10-03 | 2020-12-27 | Paclitaxel+Trastuzumab wkly Maint | 02 | N | PACLITAXEL + TRASTUZUMAB | 100334595 |
| 210003806 | 210011848 | 1.63 | 91.3 | Neo-adjuvant (N) | 2021-03-31 | 2021-08-29 | Capecitabine | N | N | CAPECITABINE | 101532763 |
| 210003807 | 210011849 | 1.67 | 84.7 | null | 2018-03-27 | 2018-04-09 | Vinorelbine (oral) | 02 | null | VINORELBINE | 100435510 |
| 210003808 | 210011850 | 1.7 | 52 | Adjuvant (A) | 2019-11-22 | 2019-12-14 | Capecitabine | null | N | CAPECITABINE | 100749803 |
| 210003809 | 210011851 | 1.49 | 69.7 | null | null | 2020-12-18 | Carboplatin AUC 6 - 10 | N | null | CARBOPLATIN | 101688181 |
| 210003813 | 210011853 | null | null | null | 2020-11-01 | 2021-01-18 | FEC 100 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101270324 |
| 210003819 | 210011857 | 1.56 | 90.8 | null | 2016-08-12 | 2016-09-22 | null | null | null | FEC | 100807799 |
| 210003822 | 210011859 | 1.64 | 57.7 | Palliative (P) | null | 2020-03-13 | EC + PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100568439 |
| 210003824 | 210011860 | 0 | 59.2 | Palliative (P) | null | 2018-11-28 | null | N | N | NAB-PACLITAXEL | 100036411 |
| 210003826 | 210011861 | 1.61 | 94.7 | null | 2020-06-02 | 2020-08-08 | Eribulin | 02 | null | ERIBULIN | 101339951 |
| 210003828 | 210011862 | 1.61 | 90 | null | 2021-10-10 | 2021-10-24 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101679686 |
| 210003829 | 210011863 | 1.72 | 67.3 | null | 2019-05-15 | 2019-05-26 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 100506263 |
| 210003832 | 210011865 | 1.7 | 70.9 | Curative (C) | 2019-05-16 | 2019-07-29 | Eribulin | 02 | N | ERIBULIN | 100586130 |
| 210003835 | 210011867 | null | 94 | Neo-adjuvant (N) | 2016-02-26 | 2016-05-13 | Capecitabine | 01 | N | CAPECITABINE | 101442024 |